Terms: = Colorectal cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
668 results:
1. Association of CD8
Yang J; Ding X; Fang Z; Wu S; Yuan M; Chen R; Xu Q; Gao X; Wu H; Chen L; Zheng X; Jiang J
BMC Cancer; 2024 Jul; 24(1):869. PubMed ID: 39030523
[TBL] [Abstract] [Full Text] [Related]
2. Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated cancers in Patients With Type 2 Diabetes.
Wang L; Xu R; Kaelber DC; Berger NA
JAMA Netw Open; 2024 Jul; 7(7):e2421305. PubMed ID: 38967919
[TBL] [Abstract] [Full Text] [Related]
3. Updated evidence of the effectiveness and safety of transanal drainage tube for the prevention of anastomotic leakage after rectal low anterior resection: a systematic review and meta-analysis.
Tamura K; Uchino M; Nomura S; Shinji S; Kouzu K; Fujimoto T; Nagayoshi K; Mizuuchi Y; Ohge H; Haji S; Shimizu J; Mohri Y; Yamashita C; Kitagawa Y; Suzuki K; Kobayashi M; Kobayashi M; Yoshida M; Mizuguchi T; Mayumi T; Kitagawa Y; Nakamura M;
Tech Coloproctol; 2024 Jun; 28(1):71. PubMed ID: 38916755
[TBL] [Abstract] [Full Text] [Related]
4. The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials.
Lai C; Xu L; Dai S
Clin Transl Med; 2024 May; 14(5):e1684. PubMed ID: 38783482
[TBL] [Abstract] [Full Text] [Related]
5. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
[TBL] [Abstract] [Full Text] [Related]
6. Association between being breastfed in infancy and adult colorectal cancer risk among Japanese men and women.
Minami Y; Kanemura S; Kusaka J; Kinouchi M; Suzuki S; Iwasashi H; Nishino Y; Kakugawa Y; Miura K
Sci Rep; 2024 Apr; 14(1):9661. PubMed ID: 38671142
[TBL] [Abstract] [Full Text] [Related]
7. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and Prognosis in Patients After Radical Resection of colorectal cancer].
Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
[TBL] [Abstract] [Full Text] [Related]
8. Endoscopic ultrasound-guided fine needle biopsy diagnosis of circumferentially extraluminal mucosa-associated lymphoid tissue lymphoma in the transverse colon: a case report.
Niwa T; Watahiki M; Kosugi T; Kusama D; Tamakoshi H; Takinami M; Kaneko J; Takahashi Y; Nishino M; Yamada T
Clin J Gastroenterol; 2024 Jun; 17(3):461-465. PubMed ID: 38607542
[TBL] [Abstract] [Full Text] [Related]
9. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
[TBL] [Abstract] [Full Text] [Related]
10.
Mahajan D; Sambyal V; Uppal MS; Sudan M; Guleria K
Genet Test Mol Biomarkers; 2024 May; 28(5):176-188. PubMed ID: 38597641
[TBL] [Abstract] [Full Text] [Related]
11. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
[TBL] [Abstract] [Full Text] [Related]
12. Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics.
Che G; Yin J; Wang W; Luo Y; Chen Y; Yu X; Wang H; Liu X; Chen Z; Wang X; Chen Y; Wang X; Tang K; Tang J; Shao W; Wu C; Sheng J; Li Q; Liu J
Drug Resist Updat; 2024 May; 74():101080. PubMed ID: 38579635
[TBL] [Abstract] [Full Text] [Related]
13. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
[TBL] [Abstract] [Full Text] [Related]
14. Management Strategies for Malignant Left-Sided Colonic Obstruction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Propensity Score Matching Studies.
McHugh FT; Ryan ÉJ; Ryan OK; Tan J; Boland PA; Whelan MC; Kelly ME; McNamara D; Neary PC; O'Riordan JM; Kavanagh DO
Dis Colon Rectum; 2024 Jul; 67(7):878-894. PubMed ID: 38557484
[TBL] [Abstract] [Full Text] [Related]
15. Precursor exhausted CD8
Huang H; Ge J; Fang Z; Wu S; Jiang H; Lang Y; Chen J; Xiao W; Xu B; Liu Y; Chen L; Zheng X; Jiang J
Front Immunol; 2024; 15():1362140. PubMed ID: 38510246
[TBL] [Abstract] [Full Text] [Related]
16. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
[TBL] [Abstract] [Full Text] [Related]
17. Underwater versus conventional endoscopic mucosal resection for ≥10 mm sessile or flat colorectal polyps: A systematic review and meta-analysis.
Wang X; Wang Y; Cao X; Zhang C; Miao L
PLoS One; 2024; 19(3):e0299931. PubMed ID: 38451998
[TBL] [Abstract] [Full Text] [Related]
18. Long-term Changes in Low Anterior Resection Syndrome in Survivors of Rectal cancer: Longitudinal Follow-up of a Randomized Controlled Trial.
He S; Zhang J; Wang R; Li L; Sun W; Wang J; Deng Y; Liang W; Dou R
Dis Colon Rectum; 2024 Jun; 67(6):834-840. PubMed ID: 38426539
[TBL] [Abstract] [Full Text] [Related]
19. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in colorectal cancer.
Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
[TBL] [Abstract] [Full Text] [Related]
20. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
[TBL] [Abstract] [Full Text] [Related]
[Next]
